Research Article
Characterization of Enhancing MS Lesions by Dynamic Texture Parameter Analysis of Dynamic Susceptibility Perfusion Imaging
Table 1
Detailed patient information.
| Pt. number | Sex | Diagnosis | Age (years) | EDSS | Disease duration | Therapy | Acute disease exacerbation/start before MRI | Symptoms of acute disease exacerbation |
| 1 | F | RR-MS | 56 | 3 | 29 y | No | No | — | 2 | F | RR-MS | 44 | 4 | First relapse 5 months ago | No | No | — | 3 | F | RR-MS | 23 | 1 | 4.5 months | No | No | — | 4 | F | SP-MS | 35 | 5 | 14 y | No | Yes/5 months | Mild paresis left leg/impaired walking | 5 | F | RR-MS | 42 | 4 | 5 months | No | Yes/2–5 months | Tetraspasticity/urinary urgency | 6 | F | SP-MS | 60 | 7.5 | 19 y | No | Yes/2 d | Subacute hemiparesis left | 7 | F | RR-MS | 50 | 3.5 | 8 y | Yes (interferon beta 1b) | No | — | 8 | M | SP-MS | 74 | 7 | 25 y | No | Yes/1 d | Worsening of paraparesis | 9 | F | RR-MS | 44 | 4 | 22 months | No | Yes/3 weeks | Vertigo, weakness in right leg, tongue sensation left | 10 | M | RR-MS | 30 | 1.5 | 12 months | Yes (interferon beta 1b) | Yes/10 d | Weakness in left leg and arm | 11 | M | RR-MS | 28 | 2.5 | 7 months | No | Yes/3 months | Retrobulbar pain, eye lid twinkles | 12 | F | RR-MS | 24 | 3 | 3.5 y | Yes (glatiramer acetate) | Yes/1 month | Urinary urgency/vertigo |
|
|
Note: RRMS: relapsing-remitting MS, SPMS: secondary progressive MS, and EDSS: Expanded Disability Status Scale.
|